Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc

    NNASDAQ:AVDL
    0.02
    USD
    0.00
    (0.00%)
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    0.3
    0.16
    0.41
    4.26
    3.64
    4.28
    2.77
    1.58
    0.42
    - -
    - -
    0.35
    1.78
    2.57
    Basic EPS, GAAP
    -0.13
    -1.69
    -2.36
    1.03
    -1
    1.69
    -2.55
    -0.89
    0.13
    -1.32
    -2.29
    -2
    -0.51
    - -
    Free Cash Flow per Basic Share
    -0.97
    -0.85
    -0.34
    2.04
    0.43
    -0.92
    -2.76
    -1.03
    -0.92
    -1.32
    -1.18
    -1.6
    -0.49
    0.36
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -7.53
    -9.11
    -8.68
    -6.71
    -7.74
    -6.48
    -9.58
    -10.45
    -7.24
    -7.64
    -9.73
    -9.29
    -8.34
    -8.15
    Tangible Book Value per Share
    -1.18
    -2.68
    -0.61
    0.86
    0.02
    -0.62
    -0.46
    -1.3
    2.74
    1.05
    -0.63
    0.88
    0.6
    0.84
    Basic Weighted Avg Shares
    25
    25
    36
    41
    41
    40
    37
    37
    53
    59
    60
    80
    95
    97
    Sales/Revenue/Turnover
    8
    4
    15
    173
    150
    173
    103
    59
    22
    - -
    - -
    28
    169
    249
    Operating Margin (%)
    -286.4
    -611.75
    -221.39
    58.79
    29.5
    35.21
    -58.64
    -28.42
    -164.15
    - -
    - -
    -492.97
    -25.07
    1.82
    Depreciation Expense
    3
    3
    14
    13
    14
    5
    7
    2
    2
    1
    1
    2
    3
    4
    Net Income, GAAP
    -3
    -43
    -85
    42
    -41
    68
    -95
    -33
    7
    -77
    -137
    -160
    -49
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    46.21
    - -
    26.32
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    62.96
    Profit Margin (%)
    -42.85
    -1,027.16
    -570.74
    24.16
    -27.47
    39.41
    -92.29
    -56.11
    31.47
    - -
    - -
    -573.17
    -28.87
    -0.11
    Working Capital
    11
    -7
    41
    121
    119
    37
    86
    46
    248
    171
    45
    97
    85
    110
    LT Debt
    33
    66
    1
    1
    1
    - -
    116
    124
    130
    144
    92
    2
    1
    2
    Total Equity
    31
    -10
    25
    69
    42
    86
    3
    -29
    162
    78
    -21
    88
    74
    98
    Return on Invested Capital (%)
    - -
    - -
    - -
    97.94
    - -
    68.97
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    -14.37
    - -
    -23.79
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -19.93
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    1
    1
    1
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    2
    2
    2
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    97
    97
    97
    Market Capitalization
    755
    854
    1,477

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    139
    159
    172
    Cash, Cash Equivalents & STI
    66
    82
    92
    Accounts Receivable, Net
    42
    41
    42
    Inventories
    20
    23
    24
    Total Current Liabilities
    51
    57
    62
    Payables & Accruals
    30
    32
    31
    ST Debt
    1
    1
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -237.04%
    -273.06%
    -15.83%
    Free Cash Flow
    -94.74%
    18.99%
    -63.5%
    Net Income, GAAP
    -221.44%
    -259.32%
    -69.53%
    Sales/Revenue/Turnover
    - -
    - -
    504.79%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    1
    7
    19
    28
    2024
    27
    42
    50
    50
    169
    2025
    53
    68
    77
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.48
    -0.83
    -0.41
    - -
    -2
    2024
    -0.3
    -0.14
    -0.03
    -0.05
    -0.51
    2025
    -0.05
    0.1
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News